Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controlled High-risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance (CHAMPIONS10)

NCT00179478 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT00179478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00179478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controlled High-risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurologic Surveillance (CHAMPIONS10)
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2001
Completion date
March 31, 2009
Enrollment
155 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

acute brainstem/cerebellar syndrome, multiple sclerosis, optic neuritis, transverse myelitis